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Purpose: To assess lilac artery stenosis before and up to 1 year after percutaneous 
transluminal ngioplasty (PTA) with duplex ultrasound (DUS) to determine the incidence 
of  residual and recurrent stenoses and correlate these findings to clinical outcome. 
Patients and Methods: Sixty-one patients with 70 iliac artery segments treated with PTA 
were examined. The peak systolic velocity (PSV) ratio (PSV ratio = PSV in stenosis + PSV 
proximal or distal to stenosis) was determined by DUS before PTA and 1 day, 3 months 
and I year after PTA. Three categories of  results were identified by using PSV ratios at the 
site of  the treated stenosis 1 day and 1 year after PTA (good result, residual stenosis, and 
recurrent stenosis). The DUS-determined anatomic result was correlated with the clinical 
outcome at 1 year. Clinical outcome was classified according to Society for Vascular 
Surgery/ International  Society for Cardiovascular Surgery (SVS/ ISCVS) criteria. 
Results: Good results with DUS (PSV ratio 1 day and 1 year after PTA >2.5) were found 
in 45 of  70 segments (64.3%), residual stenoses (PSV ratio >2.5 1 day after PTA) in 15 of  
70 segments (21.4%), and recurrent stenoses (PSV ratio 1 day after PTA <2.5 and 1 year 
after PTA >_2.5) in 10 of  70 segments (14.3%). PSV ratios of  residual stenoses decreased 
significantly between i day and i year after PTA because some residual stenoses improved 
hemodynamically in time. Clinical results were significantly better in patients with a good 
result compared with other patients. However, the clinical outcome of  patients with 
residual stenoses was not significantly different from the patients with good DUS results. 
Conclusion: Some residual stenoses improved sonographically after PTA. Clinical results at 
1 year are highly variable within different groups. Clinical outcome of  patients with 
residual stenoses did not differ from patients with good DUS results, whereas clinical 
outcome in patients with recurrent stenoses was worse than in the other groups. (J VASC 
SURG 1996;23:691-7.) 
Percutaneous transluminal angioplasty (PTA) of  
the iliac vessels is a well-established method of  treating 
patients with iliac artery stenoses. The acceptance of  
this method is based on several clinical studies that 
have shown its efficacy. These studies rely on nonin- 
vasive tests such as the ankle-brachial index (ABI) and 
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the walking distance. They show an initial technical 
failure rate o f  10% and a recurrence ratc of  10% at 1 
year, which amounts to a 20% failure ratc at thc end o f  
the first year. 1-9 
Little is known about thc natural history of  
residual stenoses, although clinical practice has shown 
that some of  these stenoses can improve over t imeJ  ~ 
Recurrent stenoses can develop as well. In these 
patients the initial result is good,  but within some time 
stenoses develop. This f inding can be related to 
intimal prolifkration or progression ofatherosclerot ic  
disease. 
Unti l  now, angiography has been the most impor- 
tant method for obtaining quantitative information 
about iliac artery stenoses and their location. How-  
ever, no consistent fbllow-up study that uses this 
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Table  I. SVS/ ISCVS categories and results classification 
Grade Category Clinical description Objective criteria 
0 0 Asymptomatic, no hemodynamically Normal results of treadmill/stress te t 
significant occlusive disease 




2 Moderate claudication 
Severe claudication 
Ischemic rest pain 
Minor tissue loss, nonhealing ulcer, 
focal gangrene with diffilse pedal is- 
chemia 
6 Major tissue loss, extending above APrest <40 mm Hg 
transmetatarsa] level, functional foot 
no longer salvageable 
Treadmill exercise completed, APexc 
>50 mm Hg but ->25 mm Hg less 
than APrcst 
Treadmill exercise completed and APexc 
<50 mm Hg or treadmill exercise 
not completed and APexc _>50 
mm Hg 
Treadmill exercise not completed and 
APexc <50 mm Hg 
APrest <60 mm Hg 
APrest <40 mm Hg 
Treadmill test: 330 m (5 minutes 4 km/hour, no slope). 
AP, Ankle pressure; APexc, ankle pressure after exercise; APrest, ankle pressure at rest. 








Normalization, improved to category 0
Moderate improvement, atleast 1 cat- 
egory improvement 
Minimal improvement, atleast 1 category 
improvement or unchanged 
Unchanged 
Mild worsening of symptoms, no cat- 
egorical shift 
Moderate worsening, 1category worse 





<0.90 and ABI improved >0.10 
ABI improved _< 0.10 
ABI improved > 0.10 
ABI improved <0.10 
ABI decreased >0.10 
Unexpected minor amputation 
Unexpected major amputation 
From Rutherford et al. 17A8'21 
technique has been reported in the l i terature- -prob-  
ably because of  the invasiveness of  the method.  
Recently, duplex ultrasound (DUS)  has been increas- 
ingly used. It  is a method that can provide information 
about the severity o f  stenoses and their precise loca- 
t ion in vessels. The method has been validated by 
comparing it with intravascular pressure measure- 
ments.Ira6 Because DUS is noninvasive, it can be used 
repeatedly. 
We undertook  a 1-year fbl low-up study o f  lilac 
artery stenoses after PTA. The aim of  our study was to 
determine how often DUS detected stenoses after 
angioplasty and in which t ime interval these stenoses 
appeared. To determine the clinical meaning of  these 
stenoses, the DUS results were l inked to the clinical 
results quantified according to the Society for Vascu- 
lar Surgery / Internat iona l  Society for Cardiovascular 
Surgery (SVS/ ISCVS)  results classification. 17a8 
PAT IENTS AND METHODS 
Between September 1989 and July 1991, 63 
patients with 72 lesions in the lilac artery were selected 
to be treated with PTA. The indication for PTA was 
lifestyle-limiting claudication in 59 patients and rcst 
pain in four. Technical failure occurred in two patients 
with a single lesion because the guide wire could not 
cross the stenosis. Sixty-one patients were treatcd 
with PTA on 68 stenosed lilac artery segments and 
two occluded common iliac artery segments. Fort3,- 
two lesions were situated in the common lilac artery, 
and 28 lesions in the external iliac artery. O f  these 
patients, 48 were men and 13 were women with a 
mean age o f  58.8 years (range 35 to 83 years). 
According to the clinical categories o f  chronic l imb 
ischemia, patients with 10 segments were listed in 
category 1 (mild claudication), 43 in category 2 
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PSV ratio > 2.5 or < 2.5 
Segments 1 day post PTA 3 months post PTA 1 year post PTA 
res,0ua, 
>25 ~ ~ ~ ( ~  reculTent 
(~ rgesul~ 
~ <2~~5 ~ ~  ~ recurrent 
(~ rgesul~ 
Fig. 1. Evolution in time of PSV ratios ()fall segments befbre alld after PTA. 8", 8 occlusions; 
9", 9 occlusions. 
(moderate claudication), 10 in category 3 (severe 
claudication), and 3 in category 4 (ischemic rest pain) 
(Table I). TM In four patients, not enough data were 
available to determine the pre-PTA clinical category, 
although aclinical result could be determined in 3 of 
4 patients. Additional risk factors were hypertension 
in 15 patients, diabetes in five, and smoking in 50. In 
the year of the follow-up, none of the patients died 
and none underwent vascular surgery for the leg that 
was treated. 
The patients received 100 mg aspirin 1 day befbre 
PTA; this dosage was continued for at least 3 months. 
If the patient was receiving anticoagulation therapy, 
no aspirin was given and the anticoagulation therapy 
was continued. During the procedure some patients 
received heparin or nitroglycerin f deemed necessary. 
PTA was performed according to standard meth- 
ods. A 6, 7, or 8F sheath was used in the procedures; 
the size of the balloon was chosen by measuring the 
proximal or distal arterial lumen that appeared normal 
on the angiogram. After the balloon was positioned 
across the stenosis, dilation was performed with a 
manometer-recorded pressure of 5 to 10 atmo- 
spheres. PTA was considered successful if the angio- 
gram showed a good morphologic result with a 
diameter reduction <30% after PTA. When the result 
was not satisfactory, PTA was repeated either with the 
same balloon or with a balloon with a larger diameter. 
If the dilated vessel segment did not further espond 
after epeated ilation, the procedure was terminated. 
The procedures performed on these patients were not 
considered to be initial technical failures, and all these 
patients were included in the follow-up. PTA was 
considered to be an initial technical failure only when 
the guide wire or balloon catheter could not pass 
through the stenosis. These procedures were per- 
formed when endovascular stents were not available 
to the radiologists in our hospital. 
DUS studies were performed with an ATL Ultra- 
mark 5, 8, and 9 machine (Advanced Technology 
Laboratories, Bothell, Wash.). A phased array 
(3 MHz), a linear array (5 MHz), or a mechanical 
section (5 /7 .5 /10  MHz) transducer probe was used. 
The Ultramark 9 machine was equipped with color 
Doppler. The iliac artery was first visualized with color 
if available. The peak systolic velocity (PSV) was 
determined fi:om the Doppler spectrum, acquired by 
positioning the Doppler sampling gate centerstream 
in the flow after Doppler angle correction with a 
maximum of 60 degrees. The PSV was measured in 
the stenosis and in a normal-appearing proximal or 
distal segment, depending on the site of the stenosis. 
The PSV of an origin stenosis was compared with 
the PSV in a distally located normal segment because 
the lumen diameter of the comparing vessel should 
be similar in size. The PSV ratio was obtained by 
dividing the PSV in the stenosis by the PSV in the 
normal proximal or distal segment. As has been 
documented in the literature, a lesion with a PSV ratio 
>2.5 represented a hemodynamically significant 
stenosis. 14,19.20 
The patients were evaluated with DUS within ] 
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Table I I .  Clinical results at 1 year 
Result -3  -2  -1  0 +1 +2 +3 ~ml  
All segments* 0 1 0 
Segments good result 0 0 0 
Recurrent stcnoscs 0 1 0 
Residual stenoses 0 0 0 
All stenoses']" 0 1 0 
9 21 16 22 69 
3 13 11 17 44 
4 2 2 1 10 
2 6 3 4 15 
6 8 5 5 25 
*Data in one patient not available. 
~'Recurrent s enoscs +residual stcnoscs. 
Table I I I .  Duplex ultrasound rcsults at 1 
year compared with clinical results at 1 year 
Clinical results 
DUS results Success No change~deterioration 
PSV ratio <2.5 46 3 49 
PSV ratio _>2.5 13 7 20 
59 10 69 
u = 69 Segments in 60 patients 
week befbrc PTA, within 24 hours after PTA, and 3 
months and 1 year after PTA. With DUS we defined 
a good result after PTA whcn the PSV ratio was <2.8 
at 1 day and 1 year after PTA. A residual stenosis was 
defined as a PSV ratio >2.5 1 day after PTA, irrespec- 
tive of the PSV ratio at 1 year. A recurrent stenosis was 
considered to be present when the PSV ratio was <2.5 
1 day alter PTA but >2.5 at 1 year. 
To determine the clinical success at 1 year, the 
SVS/ ISCVS results classification was used comparing 
the prc-PTA values with the results at 1-year tbl- 
low-up (Table I). This resulted in a clinical score of+3 
tbr an excellent result to - 3 for severe deterioration. 
Clinical success included +1, +2, and +3 results. No 
change or deterioration included 0, -1,  -2,  and -3  
results. The change in walking distance, ABI, and 
anklc pressures are all incorporated in this classifica- 
tion. 17"1~'2' The walking distance was measured with a 
treadmill test, exercising the patient fbr 5 minutes 
with a walking velocity of 4 km/hr  without a slope in 
the treadmill. ABI was mcasurcd belbre the treadmill 
test (at rest) and after 1 minute after exercise. 
Statistical analysis was performed by using the 
paired t test for comparing PSV ratios and the 
Wilcoxon two-sample test for comparing the clinical 
results tbr the diffkrent groups of treated segments. 
RESULTS 
Sixty three patients with 72 lesions were treated 
for iliac artery stenoses. In two patients with single 
lesions the guide wire could not cross the stenosis and 
PTA was not perfbrmed. These patients were elimi- 
natcd from the study because no fbllow-up after PTA 
could bc pcrfbrmed. So 61 paticnts with 70 treated 
iliac artery segments were included in the follow-up 
study. Of  the patients with sevcral iliac PTA sites, 
seven were treated on both sides, and one patient was 
treated in both common iliac arteries and one external 
iliac artery. Sixty-five segmcnts were evaluated with 
DUS befbre PTA. Seventy segments were cvaluatcd 
with DUS within 1 day, 3 months, and 1 year after 
PTA. 
The evolution in time of the segmcnts i shown in 
Fig. 1. According to our DUS criteria 45 segments 
(64.3%) had a good result, 15 segments (21.4%) had 
a residual stenosis, and 10 segments (14.3%) had a 
recurrent stenosis. 
For all scgments there is a significant difference 
between the PSV ratios befbre PTA and 1 day and 1 
year alter PTA (p < 0.05). The finding tbr the seg- 
ments with a good result is similar (p < 0.05). For the 
segments with a recurrent stenosis the PSV ratio at 1 
vear after PTA did not difIkr significantly ftom the 
PSV ratio belbre PTA (p = 0.35). The segments with 
a residual stenosis showed a significant difference 
between the PSV ratio 1 day aider PTA and 1 year after 
PTA (p < 0.05) with a significant improvement of the 
PSV ratio within 1 year after PTA. 
The clinical results classification could be deter 
mincd ftom the data available before PTA and 1 year 
aftcr PTA in 60 patients with 69 PTA sites. In one 
patient, fbllow-up data at 1 year were not sufficient o 
analyze the clinical result. The clinical results at 1 year 
are given in Table II fbr all segments, lesions with a 
good result, all stenoscs, residual stcnoscs, and recur 
rent stcnoscs. There is a significant difference betwcen 
the group with a good result and the group of all 
stenoses. There is also a significant diff~rcnce between 
the results of the group with a good result and the 
group with recurrent stenoscs (p < 0.05). However, 
no significant difference is found between the clinical 
results of the patients with a good result and the 
patients with a residual stenosis (p = 0.15). 
In our study we found two patients who devel- 
oped an occlusion at the PTA site within 1 year after 
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PTA. Thc first patient had a poor initial result (PSV 
ratio =4.1),  which remained similar at 3 months 
(PSV ratio = 4.5). An occlusion was present at 1 year 
(no PSV ratio). The clinical score at 1 year was 0. The 
other patient had an initially good result (PSV ra- 
tio = 2.0), showed a little improvement a 3 months 
(PSV ratio = 1.7) and had developed an occlusion at 
1 year. The clinical score was 0. 
PSV ratios at 1 year arc compared with clinical 
results at 1 year in Table Il l. PSV ratios at 1 year 
showed 20 stenoscs (10 recurrent stenoses + 10 per- 
sistent residual stenoscs) and 50 lesions without a 
stcnosis (Table I). Clinical results arc analyzed for 
each patient segment. In one patient with three PTA 
sites, two lesions were located unilaterally, showing a 
clinical result in that patient according to two PTA 
sites. All double lesions in one patient were situated 
on contralateral sides. Of  49 segments with PSV ratios 
<2.5 at 1 year; 46 segments howed clinical success 
and three did not improve clinically. Of  20 segments 
with PSV ratios ->2.5 at 1 year, 13 resulted in clinical 
success and seven did not. This shows that 65% of 
paticnts with a stcnosis detected with DUS 1 year after 
PTA can still benefit ?om the procedure i year after 
PTA. 
D ISCUSSION 
Most iliac artery angioplastics result in a sono- 
graphically good result at 1 day, 3 months, and 1 year. 
In our group of 70 treated segments, 45 showed a 
good result at 1 year according to the DUS criteria. 
Nevertheless, three of these patients remained clini 
cally unchanged (Tables II and Il l). This finding 
shows that even with a good hemodynamic result at 1 
year, some patients will not benefit clinically after 
PTA. Progression of atherosclcrotic lesions at other 
sites can be a reason tbr this finding. Smoking and 
minimal cxcrcisc can also bca reason for diftkrencc in 
clinical outcome because there is evidence in the 
literature that smoking cessation and an exercise 
program also affcct clinical results of patients without 
treatment with PTA. 2~ As expected, patients with 
good DUS results at 1 ycar did clinically significantly 
better than patients with a residual or recurrent 
stcnosis. 
A subset of iliac artcry angioplastics resulted in a 
residual PSV ratio _>2.5. This was believed to represent 
a rcsidual stenosis, although there is some disagree- 
ment regarding the cause of immediate postangio- 
plasty high frequency changes at the angioplasty site. 
Some of these high PSV ratios fell below 2.5 at 3 
months and 1 year, representing some degree of 
change in the morphologic ondition of the angio- 
plasty site. The high PSV ratio found just after PTA in 
these segments is probably caused by thrombotic 
material on the vessel wall or by intramural hemato- 
mas that apparently can heal. The nine segments with 
a high PSV ratio at 1 day and at 3 months showed a 
decrease in PSV ratio too, although they remain above 
the level of  2.5 at 1 year. Endovascular stents currently 
are being used to treat iliac artery obstructions. These 
stents hould be particularly effective when a residual 
stcnosis remains directly after PTA. Because this study 
was performed before stents were available in our 
hospital, it was possible to analyze hcmodynamics of
residual stenoses during the follow-up period after 
PTA. These results how that one should be cautious 
about saying that an iliac PTA is a failure when DUS 
shows high PSV ratios 1 day after PTA. The majority 
of patients in this group still benefit from the proce- 
dure at 1 year (86.7%). A second subset ofiliac artery 
angioplasties gives a 1-day PSV ratio <2.5 but a 
3- month to 1 -year PSV ratio _>2.5. We believe that this 
finding represents a recurrent stenosis probably re- 
lated to neointimal hyperplasia. DUS can play an 
important role in detecting patients who develop 
recurrcnt arterial stenosis after angioplasty. The 1-day 
post-PTA PSV ratio in this group was not statistically 
different from that of the segments with a good result; 
this finding demonstrates that a residual stenosis is not 
an important thctor in a recurrence. 
The clinical outcome of patients with sonographi- 
cally demonstrated lilac artery stenosis is highly vari- 
able. Many factors can lead to a clinical outcome that 
diverges from the DUS results of a stenosis. Exercise 
programs and smoking cessation will influence clinical 
results of a patient and could be an explanation for 
inconsistencies between anatomic and physiologic 
improvement. 22 Two of the patients with DUS data 
showing occlusion at 1 year had no change of their 
clinical symptoms, whereas 72% of  the patients with 
recurrent and residual stenoses had substantial c inical 
improvement. It is remarkable to find that the clinical 
results in the residual stenosis group are not signifi 
cantly different from the group with a good DUS 
result. I fa  gain o f+ l  or more in the results classifica- 
tion is considered a clinical success, 13 of  15 residual 
stenoses can be said to have been successfully treated 
(86.7%). I f  we compare the clinical results in the 
group with an initially good DUS result (group with 
a good result + group with a recurrent stenosis) to 
those with a residual stenosis, the difference becomes 
even less (p = 0.3). 
In this study 85.5% of the patients represents a 
clinical success at I year. This result seems to be in line 
with those reported in the literature.l'2'6'7 In general a
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technical failure rate o f  10% and a recurrence rate in 
the first year o f  10% amounts to a failure rate of  20% 
at the end o f  the first year. 
DUS has recently been used to predict long-term 
clinical results after PTA. Sacks et al.zs correlated the 
PSV ratio after PTA to the post-PTA angiogram, the 
ABI,  and pulse volume recordings in 25 patients with 
lilac and femoral artery stenoses. He found the PSV 
ratio to often be misleading and unsuitable for evalu- 
ating the presence o f  residual stenoses after PTA. 
However,  post-PTA angiograms are notor iously dif- 
ficult to interpret and quantify. Recently Mewissen et 
al.24 correlated post -PTA PSV ratios to the long-term 
results after PTA o f  the femoral artery. He found a 
PSV ratio >2.0 after PTA to be predictive for poor  
long-term results. Mil ler et al.2s surveyed 89 endo- 
vascular procedures dur ing 1 year. He  used color 
DUS and ABI as a fol low-up method.  He  concluded 
that DUS is useful as an investigative tool and can 
locate the site o f  stenosis precisely. DUS can differ- 
entiate a residual stenosis from progression o f  disease 
at another site. 
There are several drawbacks to our study. First, it 
can be difficult to locate the same point  in the vessel 
segment in consecutive investigations with DUS. One 
cannot be absolutely certain that a stenosis has devel- 
oped close to but not  exactly at the former PTA site. 
However,  the DUS examination was always done in 
the region where bal loon di lation had occurred. 
Second, the patient populat ion in our study consisted 
mainly o f  patients with claudication; only a few 
patients had rest pain or  tissue necrosis. In most 
studies more patients belonging to these worse cat- 
egories are present, and caution should be taken in 
extrapolating the results o f  this study to these patient 
groups. Third,  no control  angiograms during the first 
year after PTA were per formed in the group with 
residual or recurrent stenoses. Progression o fathero-  
sclerotic disease in segments proximally or distally to 
the iliac artery will influence the clinical result in these 
patients. 
In conclusion, after PTA of  iliac artery stenoses, 
most PTA sites show sonographical ly good  results at 
1 year. Residual stenoses improve significantly within 
1 year after PTA as measured with DUS. Clinical 
outcome at 1 year is highly variable when results are 
compared between groups o f  patients with different 
DUS results. 
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